Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical)

v3.21.1
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Consolidated Statements of Changes in Stockholders' Equity (Deficiency)    
Gross proceeds $ 12,503,750  
Gross proceeds from Issuance of common stock and warrants in follow-on public offering 20,699,992  
Issuance costs 1,898,005 $ 127,122
Issuance cost on public offering $ 1,810,080